quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:38:02·43d
INSIDERFiling
Kiniksa Pharmaceuticals International plc logo

SEC Form 4 filed by Kiniksa Pharmaceuticals International plc

KNSA· Kiniksa Pharmaceuticals International plc
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • KNSA
    Kiniksa Pharmaceuticals International plc
    Health Care

Recent analyst ratings

  • Feb 19UpdateCanaccord Genuity$62.00
  • Sep 29UpdateTD Cowen$60.00
  • Mar 13UpdateCitigroup$40.00
  • Sep 13UpdateJefferies$40.00
  • May 3UpdateWells Fargo$34.00
  • Dec 29UpdateB of A Securities$34.00

Related

  • PR17h
    Kiniksa Pharmaceuticals to Report First Quarter 2026 Financial Results on April 28, 2026
  • SEC7d
    SEC Form DEFA14A filed by Kiniksa Pharmaceuticals International plc
  • SEC7d
    SEC Form DEF 14A filed by Kiniksa Pharmaceuticals International plc
  • INSIDER10d
    SEC Form 4 filed by Megna Michael R
  • INSIDER10d
    SEC Form 4 filed by Moat Ross
  • SEC14d
    SEC Form 144 filed by Kiniksa Pharmaceuticals International plc
  • INSIDER15d
    SEC Form 4 filed by Tessari Eben
  • INSIDER15d
    SEC Form 4 filed by Ragosa Mark
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022